MDNews - Lower Hudson/Bronx

September 2014

Issue link: https://viewer.e-digitaledition.com/i/371410

Contents of this Issue

Navigation

Page 15 of 23

THE DEVELOPMENT OF A TEST THAT MAY MAKE IT POSSIBLE TO PREDICT ALZHEIMER'S DISEASE YEARS BEFORE SYMPTOMS APPEAR HAS WIDE-RANGING IMPLICATIONS FOR PHYSICIANS, DRUG DEVELOPERS AND PATIENTS. for Alzheimer's Raises Medical  Possibilities, Ethical Questions A L Z H E I M E R ' S C L A I M S T H E lives of half a million elderly Americans annually, accord- ing to some estimates. Older people are particularly cognizant of the danger: More than a third of women 60 or older say they fear Alzheimer's more than any other disease, including cancer. With the number of people 65 or older expected to nearly double by 2050, Alzheimer's diagnoses will likely continue to rise. Social services and supportive therapy can render the pro- gression of the disease somewhat more tolerable for patients and families, but no medical treatments available today slow or cure Alzheimer's. At most, medical therapies provide temporary symptom management. Into this bleak picture comes a new blood test with the potential to predict Alzheimer's before it causes symptoms — up to three years out, in fact. Led by neurologists at Georgetown Medical University, the study was reported in Nature Medicine in March. The researchers began by studying 525 healthy people and identifi ed a set of 10 lipid metabolites in blood plasma. Lower-than-normal levels of these 10 markers indicated, with 90 percent accuracy, those who would go on to develop cognitive impairment. Next, the researchers performed a fi ve-year analysis of healthy and moderately cog- nitively impaired people, confi rming the predictive validity of the biomarkers. They followed up with a cross-validation study of 41 people, with similar success. The researchers speculated that cell membrane breakdown explained why these particular biomarkers indicated Alzheimer's. "We hy pothesized that the early Alzheimer's disease pathology in the central nervous system might be detected in other tissues if the sampling and analysis methods were sensitive enough," says Mark Mapstone, PhD, Associate Professor of Neurology at University of R o c h e s t e r M e d i c a l C e n t e r i n New York and the study's lead author. "Other approaches have looked at cere- brospina l f lu id or bra in ima g ing to see what is happening du r ing t h i s pr e c l i n ic a l p e r io d , b ut w e wanted to fi nd evidence of these changes in an easily accessible fl uid where the analysis would be relatively inexpensive." The exact mechanisms of the cell By Jennifer Webster SPECIAL CLINICAL SECTION: SENIOR HEALTH 1 6 | Lower Hudson/Bronx MD NEWS ■ M D N E W S . CO M

Articles in this issue

Archives of this issue

view archives of MDNews - Lower Hudson/Bronx - September 2014